{3-[6-Fluoro-1-(2-fluoro-phenyl)-2,2-dioxo-1,2,3,4-tetrahydro-2lambda*6*-benzo[c][1,2]thiazin-3-yl]-propyl}-methyl-amine

ID: ALA1096001

PubChem CID: 25109441

Max Phase: Preclinical

Molecular Formula: C18H20F2N2O2S

Molecular Weight: 366.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNCCCC1Cc2cc(F)ccc2N(c2ccccc2F)S1(=O)=O

Standard InChI:  InChI=1S/C18H20F2N2O2S/c1-21-10-4-5-15-12-13-11-14(19)8-9-17(13)22(25(15,23)24)18-7-3-2-6-16(18)20/h2-3,6-9,11,15,21H,4-5,10,12H2,1H3

Standard InChI Key:  CLLQMGVKRYVVFS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    5.6962    6.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5622    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5622    2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9641    5.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0981    5.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6962    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6962    2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2321    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0981    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9641    6.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3660    2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2321    3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2321    2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3660    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0981    4.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8301    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0981    2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8301    2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5000    0.5000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.9641    0.5000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.8301    7.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9641    2.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4641    4.3660    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9641    3.5000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9641    3.5000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  1  0
  2  3  2  0
  2  6  1  0
  3  7  1  0
  4  5  1  0
  4 10  1  0
  5 15  1  0
  6 16  2  0
  7 18  2  0
  8  9  1  0
  8 14  2  0
  9 17  2  0
 10 21  1  0
 11 13  2  0
 11 14  1  0
 12 13  1  0
 12 15  1  0
 13 17  1  0
 14 19  1  0
 15 25  1  0
 16 18  1  0
 16 20  1  0
 17 22  1  0
 18 22  1  0
 22 25  1  0
 23 25  2  0
 24 25  2  0
M  END

Associated Targets(Human)

SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 366.43Molecular Weight (Monoisotopic): 366.1214AlogP: 3.36#Rotatable Bonds: 5
Polar Surface Area: 49.41Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.24CX LogP: 3.13CX LogD: 0.43
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.83Np Likeness Score: -0.89

References

1. Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P..  (2010)  Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,  20  (5): [PMID:20153188] [10.1016/j.bmcl.2010.01.056]

Source